相似文献
1
ISG15: A double edged sword in cancer.
Oncoimmunology. 2015 Jun 1;4(12):e1052935. doi: 10.1080/2162402X.2015.1052935. eCollection 2015 Dec.
2
Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.
Oncotarget. 2015 Mar 30;6(9):7221-31. doi: 10.18632/oncotarget.3372.
3
Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.
Cancer Res. 2006 Jan 15;66(2):921-8. doi: 10.1158/0008-5472.CAN-05-1123.
4
Interferon-Stimulated Gene 15, a Type I Interferon-Dependent Transcript, Is Involved in a Negative Feedback Loop in Innate Immune Reactions in Human Mesangial Cells.
Nephron. 2016;132(2):144-52. doi: 10.1159/000443934. Epub 2016 Feb 5.
5
ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.
Oncotarget. 2016 Nov 8;7(45):74393-74409. doi: 10.18632/oncotarget.11911.
6
ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.
Exp Biol Med (Maywood). 2012 Jan;237(1):38-49. doi: 10.1258/ebm.2011.011236. Epub 2011 Dec 20.
7
ISG15 inhibits cancer cell growth and promotes apoptosis.
Int J Mol Med. 2017 Feb;39(2):446-452. doi: 10.3892/ijmm.2016.2845. Epub 2016 Dec 30.
8
The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?
Cytokine Growth Factor Rev. 2006 Dec;17(6):411-21. doi: 10.1016/j.cytogfr.2006.10.001. Epub 2006 Nov 13.
9
Identification of an interferon-stimulated gene, isg15, involved in host immune defense against viral infections in gilthead seabream (Sparus aurata L.).
Fish Shellfish Immunol. 2018 Feb;73:220-227. doi: 10.1016/j.fsi.2017.12.027. Epub 2017 Dec 19.
10
Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infection.
J Viral Hepat. 2016 May;23(5):375-86. doi: 10.1111/jvh.12508. Epub 2016 Feb 1.
引用本文的文献
1
Curcumin inhibits IFN-γ induced PD-L1 expression via reduction of STAT1 Phosphorylation in A549 non-small cell lung cancer cells.
Saudi Pharm J. 2025 Jun 5;33(3):16. doi: 10.1007/s44446-025-00018-2.
2
Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer.
Commun Biol. 2025 May 3;8(1):696. doi: 10.1038/s42003-025-08094-9.
3
Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy.
Mol Ther Oncol. 2024 Nov 18;32(4):200906. doi: 10.1016/j.omton.2024.200906. eCollection 2024 Dec 19.
4
Transcriptome-based network analysis related to regulatory T cells infiltration identified RCN1 as a potential biomarker for prognosis in clear cell renal cell carcinoma.
BioData Min. 2024 Nov 14;17(1):51. doi: 10.1186/s13040-024-00404-x.
5
ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC.
Clin Exp Med. 2024 Jun 29;24(1):140. doi: 10.1007/s10238-024-01414-z.
6
ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis.
J Extracell Biol. 2024 Jan 31;3(2):e92. doi: 10.1002/jex2.92. eCollection 2024 Feb.
7
Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic Frontiers.
Vaccines (Basel). 2024 Feb 1;12(2):153. doi: 10.3390/vaccines12020153.
8
LncRNA BCCE4 Genetically Enhances the PD-L1/PD-1 Interaction in Smoking-Related Bladder Cancer by Modulating miR-328-3p-USP18 Signaling.
Adv Sci (Weinh). 2023 Oct;10(30):e2303473. doi: 10.1002/advs.202303473. Epub 2023 Sep 13.
9
NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome-dependent degradation of ISGylated p53.
Cancer Sci. 2023 Sep;114(9):3523-3536. doi: 10.1111/cas.15887. Epub 2023 Jun 22.
10
ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma.
J Transl Med. 2023 May 22;21(1):341. doi: 10.1186/s12967-023-04135-1.
本文引用的文献
1
Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.
Oncotarget. 2015 Mar 30;6(9):7221-31. doi: 10.18632/oncotarget.3372.
2
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
Oncogene. 2014 Feb 6;33(6):794-803. doi: 10.1038/onc.2012.633. Epub 2013 Jan 14.
3
Ubiquitin-like proteins.
Annu Rev Biochem. 2012;81:323-57. doi: 10.1146/annurev-biochem-093010-153308. Epub 2012 Mar 9.
4
ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.
Exp Biol Med (Maywood). 2012 Jan;237(1):38-49. doi: 10.1258/ebm.2011.011236. Epub 2011 Dec 20.
5
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.
Breast Cancer Res. 2008;10(4):R58. doi: 10.1186/bcr2117. Epub 2008 Jul 15.
6
ISG15 as a novel tumor biomarker for drug sensitivity.
Mol Cancer Ther. 2008 Jun;7(6):1430-9. doi: 10.1158/1535-7163.MCT-07-2345.
7
Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.
Cancer Res. 2006 Jan 15;66(2):921-8. doi: 10.1158/0008-5472.CAN-05-1123.
8
Basic Medical Research Award. The ubiquitin system.
Nat Med. 2000 Oct;6(10):1073-81. doi: 10.1038/80384.
9
Immunoregulatory properties of ISG15, an interferon-induced cytokine.
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):211-5. doi: 10.1073/pnas.93.1.211.
10
Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin.
J Biol Chem. 1987 Aug 15;262(23):11315-23.
Zotero 插件